ReGen Says Lack Of FDA Sports Med Specialists Blocks Its Knee Product

ReGen Biologics is convinced that a lack of sports medicine specialists at FDA's orthopedic devices review branch is to blame for the agency's refusal to grant 510(k) clearance for its knee cartilage repair product

More from Archive

More from Medtech Insight